Progress in Medicinal Chemistry

Author:   Brian Cox (Professor, University of Sussex, Brighton, UK) ,  David R. Witty (WITNET LTD, Cambridge, UK)
Publisher:   Elsevier - Health Sciences Division
ISBN:  

9780323850568


Pages:   452
Publication Date:   17 June 2021
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $530.64 Quantity:  
Add to Cart

Share |

Progress in Medicinal Chemistry


Add your own review!

Overview

Progress in Medicinal Chemistry, Volume 60 provides a review of eclectic developments in medicinal chemistry. Each chapter is written by an international board of authors who cover topics including Venoms in Drug Discovery, Designing Protacs as a Drugs, Automated synthesis and enabling tools for Medicinal Chemistry, Use of Molecular Docking Computational Tools in Drug Discovery, and An industrial perspective on co-crystals: screening, identification and development of the less utilized solid form in drug discovery and development.

Full Product Details

Author:   Brian Cox (Professor, University of Sussex, Brighton, UK) ,  David R. Witty (WITNET LTD, Cambridge, UK)
Publisher:   Elsevier - Health Sciences Division
Imprint:   Elsevier - Health Sciences Division
Weight:   1.000kg
ISBN:  

9780323850568


ISBN 10:   0323850561
Pages:   452
Publication Date:   17 June 2021
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1. Venoms in Drug Discovery Steven Anthony Trim 2. Designing Protacs as a Drugs Edward Tate 3. Automated synthesis and enabling tools for Medicinal Chemistry Paula Louise Nichols 4. Use of Molecular Docking Computational Tools in Drug Discovery Francesca Stanzione 5. An industrial perspective on co-crystals: screening, identification and development of the less utilised solid form in drug discovery and development Thomas Kendall

Reviews

Author Information

Professor Brian Cox is at University of Sussex, Brighton, UK Dr David Witty has more than 20 years experience in the pharmaceutical industry as a medicinal chemist and project leader working principally in areas of anti-infectives, metabolic diseases, cognition and pain, delivering clinical candidates for several conditions. He led IT Strategy within the Neurology division of GSK, developing and deploying the first Electronic Notebooks for drug discovery to sites in the UK and Singapore. He has contributed more than 90 scientific papers, reviews, patents and books on medicinal and synthetic chemistry.In 2010 David and several colleagues successfully raised $35M in venture funding to found Convergence Pharmaceuticals, a specialist ion channel company focused on the development of novel treatments for pain, based in Cambridge UK. David presently leads their discovery programme and manages scientific operations within the business.David is chairman of the Fine Chemicals Group of the Society of Chemical Industry, with responsibility for the delivery of conferences, seminars and training courses for chemists throughout the UK and Europe, and advising parliamentary bodies on matters of relevance to the UK chemical industry.Since 2008 David has been a STEM ambassador for SETPOINT, introducing school students at both primary and secondary level to the excitement and possibilities of pursuing scientific careers, through workshops, lectures and competitions.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List